BHICOTCServices-Computer Processing & Data PreparationFiscal year ends December 31

BioScience Health Innovations, Inc.

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026

$6.78+0.00 (0.00%)

Close on Oct 16, 2026

Market cap: $79.22M
P/E (TTM): –
Dividend yield: –

BioScience Health Innovations, Inc. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-12-31	FY 2024 2024-12-31	FY 2022 2022-08-31	FY 2021 2021-08-31	FY 2020 2020-08-31
Revenue	5.69	1.84	0	0	0
Cost of Revenue	2.45	0.54	–	–	–
Gross Profit	3.24	1.31	–	–	–
Research & Development	0.04	0.03	–	–	–
Selling, General & Admin	2.21	1.15	0.09	0.03	0.01
General & Administrative	–	–	–	–	0.01
Advertising Expenses	0.07	0.13	–	–	–
Operating Expenses	2.52	1.22	0.09	0.03	0.01
Operating Income	0.72	0.09	-0.09	-0.03	-0.01
Interest Expense	–	–	–	0.00	–
Other Non-Operating Income	–	–	0.01	0	–
Pretax Income	–	–	-0.08	-0.03	–
Income Tax Expense	0.08	0	0	0	0
Net Income	0.64	0.09	-0.08	-0.03	-0.01
EPS (Basic)(per share)	0.06	0.01	–	0.00	0.00
EPS (Diluted)(per share)	0.06	0.01	–	0.00	0.00
Shares Outstanding (Basic, Weighted)(shares)	11	10	–	1.37	0.95
Shares Outstanding (Diluted, Weighted)(shares)	11	11	–	1.37	0.95

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin: 53.8%
Operating margin: -13.7%
Net margin: -14.7%
Return on equity, FY2025: 55.5%

Financial strength

Current ratio: –
Debt to equity: –
Debt to assets: –
Cash to current liabilities: –

Valuation

P/E ratio: –
Price to sales: 17.64
Price to book: 43.17
Dividend yield: –